India: access to affordable drugs and the right to health

The move to raise global standards in enforcement of intellectual property rights through the proposed multilateral Anti-Counterfeiting Trade Agreement (ACTA) will also deter generic competition.13 The agreement, purportedly a response to the global trade in counterfeit and pirated goods, negates th...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2011-03, Vol.377 (9770), p.976-977
Main Authors: Grover, Anand, Citro, Brian
Format: Article
Language:English
Subjects:
Antiretroviral drugs
Drug Costs
Drug Industry
Drugs, Generic - economics
Economic Competition
Enforcement
Foreign investment
Generic drugs
Health Services Accessibility
Human Rights - legislation & jurisprudence
Humans
India
Intellectual property
Internal Medicine
International agreements
International trade
Patents as Topic
Pharmaceutical industry
Pharmaceutical Preparations - economics
Pharmaceutical Preparations - supply & distribution
Property rights
Trade agreements
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The move to raise global standards in enforcement of intellectual property rights through the proposed multilateral Anti-Counterfeiting Trade Agreement (ACTA) will also deter generic competition.13 The agreement, purportedly a response to the global trade in counterfeit and pirated goods, negates the flexibilities available to World Trade Organization members under TRIPS with respect to enforcement of intellectual property rights.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(10)62042-9